US recommends 'pause' for single-dose Johnson & Johnson vaccine to investigate clotting reports

A box of Janssen vaccines is shown by pharmacist Zsolt Szenasi at a warehouse of Hungaropharma, a Hungarian pharmaceutical wholesale company, in Budapest, Hungary, after the arrival of the first batch of the Johnson & Johnson, US, made one-dose vaccine against the new coronavirus in the country Tuesday, April 13, 2021. The first shopment contains 28 thousand doses of Janssen. (Szilard Koszticsak/MTI via AP)

U.S. ‘Pauses’ Johnson & Johnson Vaccine After Clotting Reports The U.S. is recommending a “pause” in administrating the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the CDC and FDA said it was investigating clots and reduced platelet counts in six women post-vaccination. All six were women between the ages of 18 and 48; one died and a second is hospitalized in critical condition. More than 6.8 million doses of the J&J vaccine have been administered in the U.S. If you’ve gotten the vaccine, which one did you get? Did you have any side effects?